KSK-74: Dual Histamine H
excessive eating model
histamine H3 receptor ligands
obesity
palatable diet
sigma-2 receptor ligands
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Jun 2022
24 Jun 2022
Historique:
received:
20
05
2022
revised:
15
06
2022
accepted:
20
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Many studies involving compounds that enhance histamine release, such as histamine H
Identifiants
pubmed: 35806019
pii: ijms23137011
doi: 10.3390/ijms23137011
pmc: PMC9266460
pii:
doi:
Substances chimiques
Histamine Antagonists
0
Ligands
0
Receptors, Histamine H3
0
Receptors, sigma
0
sigma-2 receptor
0
Histamine
820484N8I3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Science Center
ID : 2016/23/B/NZ7/01063
Références
Circulation. 2005 Feb 22;111(7):932-9
pubmed: 15710760
Trends Pharmacol Sci. 2006 May;27(5):279-84
pubmed: 16584790
Inflamm Res. 2009 Nov;58(11):727-36
pubmed: 19543691
Diabetologia. 2009 May;52(5):882-90
pubmed: 19252892
Pol J Pharmacol. 2001 Nov-Dec;53(6):701-7
pubmed: 11985350
Eur J Pharmacol. 2004 Mar 8;487(1-3):183-97
pubmed: 15033391
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70
pubmed: 12756299
Metab Brain Dis. 2018 Jun;33(3):733-740
pubmed: 29297106
Exp Biol Med (Maywood). 2002 Mar;227(3):208-13
pubmed: 11856820
Adipocyte. 2014 Apr 1;3(2):146-50
pubmed: 24719789
Nutrients. 2013 Apr 12;5(4):1218-40
pubmed: 23584084
J Psychopharmacol. 2012 Sep;26(9):1271-9
pubmed: 22695490
Front Neurosci. 2017 Feb 08;11:50
pubmed: 28228713
Clin Endocrinol (Oxf). 2006 Apr;64(4):355-65
pubmed: 16584505
Pharmaceuticals (Basel). 2021 Oct 25;14(11):
pubmed: 34832862
Expert Opin Investig Drugs. 2005 Mar;14(3):223-41
pubmed: 15833055
ACS Chem Neurosci. 2022 Jan 5;13(1):1-15
pubmed: 34908391
Obes Res. 2004 Jun;12(6):962-71
pubmed: 15229336
Front Biosci (Schol Ed). 2012 Jan 01;4(2):461-88
pubmed: 22202071
Trends Pharmacol Sci. 2011 Apr;32(4):250-7
pubmed: 21414671
J Pharmacol Exp Ther. 2011 Jan;336(1):24-9
pubmed: 20864503
Eur J Med Chem. 2021 Mar 5;213:113041
pubmed: 33261900
Neuroscience. 2020 Jun 15;437:215-239
pubmed: 32360593
Basic Clin Pharmacol Toxicol. 2004 Sep;95(3):144-52
pubmed: 15447739
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
Obesity (Silver Spring). 2006 Dec;14(12):2154-62
pubmed: 17189541
Nat Rev Mol Cell Biol. 2019 Apr;20(4):242-258
pubmed: 30610207
J Adv Vet Anim Res. 2019 Dec 14;7(1):103-114
pubmed: 32219116
Int J Mol Sci. 2020 Aug 21;21(17):
pubmed: 32839413
Biochem Pharmacol. 2019 Oct;168:193-203
pubmed: 31295465
Cytokine. 2012 Oct;60(1):1-12
pubmed: 22766373
PLoS One. 2015 Jul 22;10(7):e0133494
pubmed: 26200663
J Vis Exp. 2018 Jan 7;(131):
pubmed: 29364280
Physiol Behav. 2007 Jan 30;90(1):29-35
pubmed: 17023009
Behav Brain Res. 2003 Feb 17;139(1-2):75-81
pubmed: 12642178
Arch Med Sci. 2017 Jun;13(4):851-863
pubmed: 28721154
Naunyn Schmiedebergs Arch Pharmacol. 2018 Aug;391(8):875-881
pubmed: 29802412
Physiol Behav. 2006 Jun 30;88(3):249-56
pubmed: 16782141
Bioorg Med Chem. 2018 Dec 15;26(23-24):6056-6066
pubmed: 30448256
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Horm Metab Res. 2007 Oct;39(10):707-9
pubmed: 17952830
Biomed Pharmacother. 2021 Oct;142:111952
pubmed: 34325303
Nature. 2008 Jun 5;453(7196):783-7
pubmed: 18454136
Biomed Pharmacother. 2021 Sep;141:111892
pubmed: 34229247
Bioorg Chem. 2019 Oct;91:103071
pubmed: 31362197
EMBO J. 2000 Aug 1;19(15):4046-55
pubmed: 10921885
PLoS Comput Biol. 2009 Mar;5(3):e1000324
pubmed: 19325873
Eur J Pharmacol. 1999 Jun 4;373(2-3):127-34
pubmed: 10414430
Front Endocrinol (Lausanne). 2015 Apr 24;6:55
pubmed: 25964776
NeuroRx. 2005 Oct;2(4):541-53
pubmed: 16489364
Biomolecules. 2022 Jan 22;12(2):
pubmed: 35204685
Mediators Inflamm. 2010;2010:
pubmed: 20706689
N Engl J Med. 1996 Feb 1;334(5):292-5
pubmed: 8532024
Int J Obes (Lond). 2005 Dec;29(12):1402-12
pubmed: 16151415